Whitepaper Spotlight: Proactive Biomarker Planning to Optimize Clinical Trials

Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized.  But success relies on following a plan from the start -- learn how in this free whitepaper